IPP Bureau
Advent International announces the completion of the acquision of Suven Pharma
By IPP Bureau - September 30, 2023
New Board of Directors and management team at Suven Pharma also appointed
Menarini strengthens its presence in aesthetic dermatology in India
By IPP Bureau - September 30, 2023
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
Lupin Receives EIR from U.S. FDA for its Nagpur Unit-1 manufacturing facility
By IPP Bureau - September 30, 2023
The U.S. FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
Apollo Hospitals celebrates its leadership position as the largest Cardiac care programme in India
By IPP Bureau - September 29, 2023
Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
USFDA delegation visits Divi's Laboratories’ Unit I at Choutuppal, Telangana
By IPP Bureau - September 29, 2023
The delegation's visit covered a wide range of topics
Berhyanda gets nod for acquisition of up to 76.1% stake in Suven Pharmaceuticals
By IPP Bureau - September 29, 2023
The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
Doceree raises US$ 35 million in Series B Funding
By IPP Bureau - September 29, 2023
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
Lupin's Joint Airways Initiative surpasses 10,000 patients
By IPP Bureau - September 29, 2023
USFDA inspection at Piramal Pharma’s Bethlehem facility
By IPP Bureau - September 29, 2023
Briefs: Sun Pharmaceutical Industries and Dr. Reddy’s
By IPP Bureau - September 29, 2023
Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.
Sun Pharma Canada launches Prwinlevi for treatment for acne
By IPP Bureau - September 28, 2023
WINLEVI works differently from any other topical acne treatment
Cosmo and Glenmark sign distribution and license agreements for Winlevi in Europe and South Africa
By IPP Bureau - September 28, 2023
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
Apollo Hospitals acquires partly built hospital in Sonarpur, Kolkata
By IPP Bureau - September 28, 2023
The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months
Mandaviya reviews preparedness to prevent rising dengue cases
By IPP Bureau - September 28, 2023
Minister was briefed on the nationwide dengue situation
Alkem rolls out patient awareness drive under its breathe initiative
By IPP Bureau - September 28, 2023
Education on Inhalation Therapy & Conducting Nationwide Awareness Camps, Alkem Breathe Initiative Addresses the Alarming Increase in Respiratory Diseases in India
